Teewinot Life Sciences: Teewinot Life Sciences to Participate at the 31st Annual Piper Jaffray Healthcare Conference in New York

TAMPA, Fla., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Teewinot Life Sciences Corporation ("Teewinot" or the "Company"), a global leader in the biosynthetic production of cGMP cannabinoids and cannabinoid analogs as new chemical entities, today announced Michael Luther Ph.D., Chief Executive Officer, will participate on the Future of Cannabinoid Biosynthesis Panel at the 31st Annual Piper Jaffray Healthcare Conference in New York being held from December 3rd - 5th, 2019 at the Lotte New York Palace.Panel Details:Date: Tuesday, December 3rd, 2019Time: 3:00 - 3:55 PM ETLocation: Villard Room, Lotte New York PalaceFor anyone interested in arranging a one-on-one meeting at the event, please contact the bank's representative or the Company's investor relations department.About Teewinot Life Sciences Teewinot Life Sciences is a global leader in the biosynthetic development and production of cannabinoids and their derivatives for consumer and pharmaceutical products. The Company is leveraging a unique integrated biocatalytic and chemical synthesis platform, that allows the production of an unprecedented range of cannabinoids and cannabinoid NCEs from bench ...Full story available on Benzinga.com